| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,476 |
2,100 |
$110K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
427 |
345 |
$10K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
172 |
141 |
$8K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
299 |
255 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
388 |
170 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
199 |
185 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
37 |
29 |
$904.88 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
58 |
41 |
$494.53 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
12 |
12 |
$0.00 |